Bressler Susan B

Bressler Susan B, Beaulieu Wesley T, Glassman Adam R, Gross Jeffrey G, Jampol Lee M, Melia Michele et al.

Ranibizumab led to less PDR worsening than PRP, particularly in eyes without baseline vision-impairing DME. This supports ranibizumab as an alternative PDR treatment.

Bressler Susan B, Almukhtar Talat, Bhorade Anjali, Bressler Neil M, Glassman Adam R, Huang Suber S et al.

Repeated ranibizumab injections for diabetic macular edema increased the risk of sustained IOP elevation or needing hypotensive treatment (9.5% vs 3.4%). Clinicians should monitor IOP in these patients.

Chew Emily Y, Clemons Traci E, Bressler Susan B, Elman Michael J, Danis Ronald P, Domalpally Amitha et al.

A home monitoring device for age-related macular degeneration detected CNV earlier, resulting in significantly better visual acuity at diagnosis compared to standard care, improving treatment outcomes.